Clinical Trial Update: A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant

View source ↗

Summary

This entry notes a safety-focused clinical trial of lenalidomide in adults with previously untreated multiple myeloma who are not eligible for transplant, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Lenalidomide (Revlimid) (lenalidomide)

Snippet

Sponsor: Celgene | Conditions: Multiple Myeloma | Status: ACTIVE_NOT_RECRUITING